(S)-Mephenytoin has been researched along with omeprazole in 2 studies
Studies ((S)-Mephenytoin) | Trials ((S)-Mephenytoin) | Recent Studies (post-2010) ((S)-Mephenytoin) | Studies (omeprazole) | Trials (omeprazole) | Recent Studies (post-2010) (omeprazole) |
---|---|---|---|---|---|
13 | 0 | 11 | 9,085 | 2,737 | 1,487 |
Protein | Taxonomy | (S)-Mephenytoin (IC50) | omeprazole (IC50) |
---|---|---|---|
Mcl-1 | Homo sapiens (human) | 3.1448 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.28 | |
Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 1.45 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 2.315 | |
Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 1.45 | |
WD repeat-containing protein 5 | Homo sapiens (human) | 1.7 | |
Glutathione S-transferase omega-1 | Homo sapiens (human) | 4.6 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 1.7 | |
Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | 3.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, R; Liu, Y; She, M; Wu, Z | 1 |
An, N; Bian, T; Chen, C; Gao, Y; Liu, D; Wang, H; Zhu, J | 1 |
2 other study(ies) available for (S)-Mephenytoin and omeprazole
Article | Year |
---|---|
The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Topics: Cytochrome P-450 Enzyme Inhibitors; Enzyme Activation; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Molecular Structure; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2011 |
Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4'-hydroxylation and omeprazole 5'-hydroxylation.
Topics: Anticonvulsants; Apoproteins; Aryl Hydrocarbon Hydroxylases; Computer Simulation; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Humans; Hydroxylation; Mephenytoin; Microsomes, Liver; Models, Molecular; Omeprazole; Polymorphism, Single Nucleotide; Protein Conformation; Recombinant Proteins; Saccharomyces cerevisiae; Software; Structure-Activity Relationship; Substrate Specificity | 2011 |